Bientinesi, Riccardo
 Distribuzione geografica
Continente #
EU - Europa 3.582
NA - Nord America 2.880
AS - Asia 2.029
SA - Sud America 363
AF - Africa 71
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.935
Nazione #
US - Stati Uniti d'America 2.766
IT - Italia 1.877
SG - Singapore 902
DE - Germania 439
CN - Cina 422
SE - Svezia 321
BR - Brasile 293
FR - Francia 259
VN - Vietnam 201
UA - Ucraina 181
GB - Regno Unito 119
IN - India 109
IE - Irlanda 79
JP - Giappone 76
NL - Olanda 74
ID - Indonesia 59
CA - Canada 56
HK - Hong Kong 52
RU - Federazione Russa 50
FI - Finlandia 43
BD - Bangladesh 41
MX - Messico 31
PL - Polonia 29
AR - Argentina 28
KR - Corea 26
BE - Belgio 25
ZA - Sudafrica 23
ES - Italia 22
IQ - Iraq 22
TR - Turchia 20
CH - Svizzera 14
EG - Egitto 14
EC - Ecuador 11
PH - Filippine 11
PK - Pakistan 11
AT - Austria 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CI - Costa d'Avorio 9
IR - Iran 9
MY - Malesia 8
VE - Venezuela 8
CL - Cile 7
CR - Costa Rica 7
HU - Ungheria 7
MA - Marocco 7
AU - Australia 5
CO - Colombia 5
CZ - Repubblica Ceca 5
LT - Lituania 5
PE - Perù 5
UZ - Uzbekistan 5
HN - Honduras 4
LK - Sri Lanka 4
NP - Nepal 4
DZ - Algeria 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LU - Lussemburgo 3
OM - Oman 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
BZ - Belize 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
MM - Myanmar 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MN - Mongolia 1
Totale 8.926
Città #
Singapore 501
Chandler 365
Ashburn 321
Rome 308
San Jose 251
Milan 179
Beijing 98
Ann Arbor 97
Los Angeles 89
New York 87
Jacksonville 80
Dublin 78
The Dalles 74
Ho Chi Minh City 69
San Mateo 64
Jakarta 55
Lauterbourg 54
Hanoi 50
Wilmington 47
Frankfurt am Main 46
Florence 45
Hefei 45
Hong Kong 43
Tokyo 39
Naples 38
Nanjing 37
Munich 36
São Paulo 33
Kadoma 28
Houston 25
Moscow 25
Nanchang 25
Woodbridge 25
Bari 24
Dearborn 24
Hyderabad 24
Boston 23
Dallas 22
Seattle 22
Toronto 22
Bremen 21
Brussels 21
Cattolica 21
Lawrence 21
Bologna 20
Buffalo 19
Chicago 19
Council Bluffs 19
Johannesburg 19
Redwood City 18
Santa Clara 18
Seoul 18
Verona 18
Denver 17
Stockholm 17
Marseille 16
Turin 16
Catania 15
Düsseldorf 15
Mountain View 15
Palermo 15
Princeton 15
Atlanta 14
Fairfield 14
London 14
Montreal 14
Warsaw 14
Da Nang 13
Kent 13
Lancaster 13
Nürnberg 12
Orem 12
Paris 12
Redmond 12
Boardman 11
Cagliari 11
Cairo 11
Chennai 11
San Francisco 11
Washington 11
Poplar 10
Sesto Fiorentino 10
Abidjan 9
Amsterdam 9
Baghdad 9
Baku 9
Menlo Park 9
Padova 9
Saint Petersburg 9
Charlotte 8
Genoa 8
Helsinki 8
Manchester 8
Mexico City 8
Phoenix 8
Rio de Janeiro 8
Augusta 7
Belo Horizonte 7
Bexley 7
Brooklyn 7
Totale 4.301
Nome #
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.231
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 956
Le infezioni delle vie urinarie 257
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 209
The occult urothelial cancer 200
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 190
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 172
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 172
[Overactive bladder syndrome: the social and economic perspective] 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 169
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 168
Bladder and prostate metastasis from small cell lung cancer: a rare entity 168
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 165
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 163
Antibiotic prophylaxis in urology 162
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 149
Methylation study of the Paris system for reporting urinary (TPS) categories 136
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 135
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 131
The occult urothelial cancer 131
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 130
Current status of robotic urologic surgery in Italy 129
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 124
Simultaneous surgical management of renal cancer with atrial thrombotic extension and severe chronic coronary artery disease: a case report 123
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 123
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 120
18F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study 120
Double J stent migration in the contralateral ureter during robotassisted pyeloplasty: an unique complication 120
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 118
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 117
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis 117
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis 117
Pharmacological methods for the preclinical assessment of therapeutics for OAB: an up-to-date review 116
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 114
Retigabine induces relaxations of the human bladder detrusor 108
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 107
Classification and management of sexual dysfunctions in multiple sclerosis patients: A review of current literature 102
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 101
Lifestyle in urology: Cancer 99
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 97
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 96
Managing urinary incontinence in women - a review of new and emerging pharmacotherapy 96
Robot-Assisted Radical Prostatectomy Performed with the Novel Hugo™ RAS System: A Systematic Review and Pooled Analysis of Surgical, Oncological, and Functional Outcomes 96
What can the metaverse do for urology? 94
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 92
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 92
Neurologic Urinary Incontinence, Lower Urinary Tract Symptoms and Sexual Dysfunctions in Multiple Sclerosis: Expert Opinions Based on the Review of Current Evidences 91
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 87
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 86
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 82
Managing urological disorders in multiple sclerosis patients: A review of available and emerging therapies 77
Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline? 71
Mirabegron: A review of recent data and its prospects in the management of overactive bladder 65
Patient-derived organoids in renal cell carcinoma: A review of methodologies and applications 10
Totale 9.032
Categoria #
all - tutte 32.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 0 0 0 0 0 20
2021/2022545 52 27 30 52 45 32 17 60 41 40 57 92
2022/20231.109 132 138 90 177 71 120 60 101 125 21 39 35
2023/20241.145 66 147 79 102 67 90 76 129 68 96 86 139
2024/20251.606 71 67 124 65 140 91 98 74 205 179 271 221
2025/20262.969 389 101 158 338 561 152 567 153 177 181 131 61
Totale 9.032